New York—February 24, 2009
Dr. Paget will continue his current responsibilities as Physician-in-Chief and and chairman of the Division of Rheumatology at HSS while a national search is undertaken for his successor. He will become Physician-in-Chief Emeritus following the appointment of his successor. Dr. Paget also serves as the Joseph P. Routh Professor of Medicine and Rheumatic Diseases at Weill Cornell Medical College.
“We want to take this moment to express our gratitude for all that Steve Paget has done for HSS during his 34 years of service,” said Louis A. Shapiro, president and CEO, Hospital for Special Surgery, in announcing the succession plan. “His unique dedication to assuring the highest quality of care and defining the causes and cures of musculoskeletal and autoimmune disorders through research has become part of the very fabric of this institution.”
“For Dr. Paget, it is all about the patients and what will make their lives better,” noted Thomas P. Sculco, M.D., Surgeon-in-Chief and Chief Medical Officer, at HSS. “He has worked with great vision to assure that HSS is at the pinnacle of care and research for patients with musculoskeletal disorders. Steve has been a role model and leader to his division and fellows. As a clinician, educator and clinical investigator, he has had a significant influence upon the field of rheumatology.”
“Steve Paget had had a real impact upon rheumatology education and research throughout the nation,” explained Steven Goldring, M.D., chief scientific officer, HSS. “His research activities and leadership in the areas of systemic lupus, rheumatoid arthritis, osteoporosis, the systemic vasculitides and premature atherosclerosis in autoimmune disorders have had an immeasurable effect upon these fields. He is able to integrate medicine with science and deliver on the promise of translational research to bring innovations from the laboratory to the bedside where they can improve lives.”
The chairmen of the HSS Board of Trustees, Dean O’Hare and Aldo Papone, said, “Steve Paget’s exceptional intellect, dedication and ability to attract the best and the brightest to HSS has contributed to the reputation of our institution as the best in world in it disciplines. His fundraising abilities have been an invaluable source of support for the many programs that make HSS what it is today. We are fortunate that Steve will continue to employ his many unique talents to support the hospital in an important new role.”
Under Dr. Paget’s guidance and leadership:
As Chair and fellowship training program director for many years, Dr. Paget has fostered the development of academic, research and educational leaders in rheumatology. As a result, the HSS rheumatology fellowship program is now one of the most sought after fellowships in the nation.
Dr. Paget noted, in making this announcement, that, “My tenure as Physician-in-Chief and head of the Rheumatology Division has been a wonderful experience in large part because of the incredibly talented people with whom I’ve had the opportunity to work. HSS is a truly unique institution, and I look forward in my new role to helping bring the remarkable work done here to an even broader arena where it can help even more people. I look forward as well to continuing my work teaching the next generation of doctors and caring for patients in need, which, at the end of the day, has always been the greatest reward for me.”
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the eighth consecutive year) and No. 3 in rheumatology by U.S. News & World Report (2017-2018). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic on musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.